⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29741232 | 1.00 | — | — | |
| Bromide SCHEMBL20394181 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL4891750 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL25411609 | 0.97 | — | — | |
| Formic Acid SCHEMBL27895003 | 0.87 | TDP1 (0.40) | — | |
| SCHEMBL314379 | 0.79 | — | — | |
| SCHEMBL29720188 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL27912104 | 0.77 | — | — | |
| SCHEMBL1203743 | 0.75 | — | — | |
| SCHEMBL5668716 | 0.75 | SIRT3 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276965-A1 | PROCESS FOR THE PREPARATION OF ANTIBACTERIAL COMPOUNDS | DISCUVA LTD (GB) | 2025-09-04 | — | — | US | claimed |
| EP-4334299-A1 | PROCESS FOR THE PREPARATION OF ANTIBACTERIAL COMPOUNDS | Discuva Ltd. (GB) | 2024-03-13 | — | — | EP | claimed |
| CN-117597337-A | Process for the preparation of antibacterial compounds | 迪斯库瓦有限公司 | 2024-02-23 | — | — | CN | claimed |
| WO-2022233891-A1 | PROCESS FOR THE PREPARATION OF ANTIBACTERIAL COMPOUNDS | DISCUVA LIMITED (GB) | 2022-11-10 | — | — | WO | claimed |
| US-20260109671-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | CURASEN THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12479820-B2 | Pyridin-3-yl derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-11-25 | — | — | US | disclosed |
| US-12448352-B2 | Beta adrenergic agonist and methods of using the same | CURASEN THERAPEUTICS, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250276965-A1 | PROCESS FOR THE PREPARATION OF ANTIBACTERIAL COMPOUNDS | DISCUVA LTD (GB) | 2025-09-04 | — | — | US | disclosed |
| EP-3351533-B1 | BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME | KAKEN PHARMA CO LTD (JP) | 2025-07-23 | — | — | EP | disclosed |
| US-20250223292-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED | 2025-07-10 | — | — | US | disclosed |
| EP-4551570-A1 | NOVEL COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Dong-A ST Co., Ltd. (KR) | 2025-05-14 | — | — | EP | disclosed |
| EP-4534538-A2 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | Vertex Pharmaceuticals Incorporated (US) | 2025-04-09 | — | — | EP | disclosed |
| CN-1126473-A | Carbazole derivatives with 17,20-lyase-inhibiting activity | GLAXO GROUP LTD (GB) | 1996-07-10 | — | — | CN | disclosed |
| EP-0699196-A1 | CARBAZOLE DERIVATIVES WITH 17,20-LYASE-INHIBITING ACTIVITY | GLAXO GROUP LIMITED (GB) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994027989-A1 | CARBAZOLE DERIVATIVES WITH 17,20-LYASE-INHIBITING ACTIVITY | GLAXO GROUP LIMITED (GB) | 1994-12-08 | — | — | WO | disclosed |
| EP-0109606-B1 | PROCESS FOR THE FORMYLATION OF ARYL HALIDES | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |
| US-4536344-A | USING A PHOSPINE OR PHOSPHITE | BAYER AKTIENGESELLSCHAFT (DE) | 1985-08-20 | — | — | US | disclosed |
| US-4490350-A | ADRENAL IMAGING AGENTS | ZOLLE LLSE | 1984-12-25 | — | — | US | disclosed |
| EP-0109606-A1 | Process for the formylation of aryl halides | BAYER AG (DE) | 1984-05-30 | — | — | EP | disclosed |
| US-4022897-A | 4H-PYRIDO(1,2-A) PYRIMIDIN-4-ONE DERIVATIVES | E. R. SQUIBB & SONS, INC. (US) | 1977-05-10 | — | — | US | disclosed |